Recently, McAllum et al. found that treatment with a Zn2+ metal complex increased the motor function and survival rate of SOD1-mutant mice with low Zn2+ affinity, which provided support for the further exploration of the therapeutic effect of Zn2+ supplementation on ALS [93]. Here, SOD1 is linked to amyotrophic lateral sclerosis.